Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6376 to 6390 of 7707 results

  1. Lung cancer (non-small-cell, advanced or metastatic maintenance treatment) - erlotinib (in combination with bevacizumab) [ID44]

    In development [GID-TAG388] Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Juvenile idiopathic arthritis - adalimumab [ID385]

    Discontinued [GID-TAG400]

    Technology appraisal guidance
    Discontinued

  3. Atrial fibrillation - clopidogrel (in combination with aspirin) [ID95]

    Discontinued [GID-TAG416]

    Technology appraisal guidance
    Discontinued

  4. Bempegaldesleukin with nivolumab for untreated unresectable or metastatic melanoma

    Discontinued [GID-TA10970]

    Technology appraisal guidance
    Discontinued

  5. Temozolomide for the treatment of advanced and metastatic melanoma [ID316]

    Discontinued [GID-TAG401]

    Technology appraisal guidance
    Discontinued

  6. Vandetanib for the second line treatment of non-small cell lung cancer [ID46]

    Discontinued [GID-TAG405]

    Technology appraisal guidance
    Discontinued

  7. Erlotinib in combination with bevacizumab for the maintenance treatment of advanced or metastatic non-small cell lung cancer [ID44]

    Discontinued [GID-TA11206]

    Technology appraisal guidance
    Discontinued

  8. Erlotinib in combination with bevacizumab for the second line treatment of advanced or metastatic non-small cell lung cancer [ID43]

    Discontinued [GID-TA11207]

    Technology appraisal guidance
    Discontinued

  9. Nivolumab for treating relapsed or refractory diffuse large B-cell lymphoma [ID986]

    Discontinued [GID-TA10140]

    Technology appraisal guidance
    Discontinued

  10. Eryaspase with chemotherapy for previously treated advanced or metastatic pancreatic cancer [ID3781]

    Discontinued [GID-TA10637]

    Technology appraisal guidance
    Discontinued

  11. Zio XT for detecting cardiac arrhythmias

    In development [GID-MT591] Expected publication date: TBC

    Medical technologies guidance
    In development

  12. Lifitegrast for treating dry eye disease [ID1229]

    Discontinued [GID-TA10196]

    Technology appraisal guidance
    Discontinued

  13. Avacopan for treating anti-neutrophil cytoplasmic antibody-associated vasculitis [ID1178]

    Discontinued [GID-TA10199]

    Technology appraisal guidance
    Discontinued

  14. Elivaldogene autotemcel for treating cerebral adrenoleukodystrophy [ID1284]

    Discontinued [GID-HST10038]

    Highly specialised technologies guidance
    Discontinued

  15. Baricitinib for treating active autoantibody-positive systemic lupus erythematosus [ID3997]

    Discontinued [GID-TA10892]

    Technology appraisal guidance
    Discontinued